XML 105 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMON STOCK Common Stock (Tables)
12 Months Ended
Dec. 31, 2012
Equity [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The following table provides a summary of the impact of our outstanding stock-based compensation plans on the results of operations for the periods presented:

 
 
Year Ended December 31,
 
 
2012
 
2011 (1)
 
2010
 
 
(in thousands)
 
 
 
 
 
 
 
Stock-based compensation expense
 
$
8,495

 
$
8,781

 
$
5,314

Income tax benefit
 
(3,245
)
 
(3,344
)
 
(2,019
)
Net expense
 
$
5,250

 
$
5,437

 
$
3,295

 
 
 
 
 
 
 
__________
(1) Includes a $2.5 million pre-tax charge related to a separation agreement with our former chief executive officer. See Note 17, Transactions with Affiliates, for additional information regarding the related separation agreement.
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
The following table presents the changes in our stock option awards. The aggregate intrinsic value of options outstanding for each period presented was immaterial:

 
Year Ended December 31,
 
2012
 
2011
 
2010
 
Number of
Shares
Underlying
Options
 
Weighted-Average
Exercise
Price
Per Share
 
Weighted- Average
Remaining
Contractual
Term
(in years)
 
Number of
Shares
Underlying
Options
 
Weighted-Average
Exercise
Price
Per Share
 
Number of
Shares
Underlying
Options
 
Weighted-Average
Exercise
Price
Per Share
Outstanding beginning of year, January 1,
6,973

 
$
41.09

 

 
10,306

 
$
41.90

 
10,306

 
$
41.90

Forfeited

 

 

 
(3,333
)
 
43.60

 

 

Outstanding end of year, December 31,
6,973

 
41.09

 
2.6

 
6,973

 
41.09

 
10,306

 
41.90

Exercisable at December 31,
6,973

 
41.09

 
2.6

 
6,973

 
41.09

 
10,306

 
41.60

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
In January 2012, the Compensation Committee awarded 68,361 SARs to our executive officers. The fair value of each SAR award was estimated on the date of grant using a Black-Scholes pricing model using the following assumptions:
 
Year Ended December 31,
 
2012
 
2011
 
2010
 
 
 
 
 
 
Expected term of award
6 years

 
6 years

 
5 years

Risk-free interest rate
1.1
%
 
2.5
%
 
2.5
%
Expected volatility
64.3
%
 
60.2
%
 
62.0
%
Weighted-average grant date fair value per share
$
17.61

 
$
25.22

 
$
13.26

Schedule of Share-based Compensation, Stock Appreciation Rights Award Activity [Table Text Block]
The following table presents the changes in our SARs:

 
Year Ended December 31,
 
2012
 
2011
 
2010
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Average Remaining Contractual
Term
(in years)
 
Aggregate Intrinsic
Value
(in thousands)
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Aggregate Intrinsic
Value
(in thousands)
 
Number of
SARs
 
Weighted-Average
Exercise
Price
 
Aggregate Intrinsic
Value
(in thousands)
Outstanding beginning of year, January 1,
50,471

 
$
31.61

 
8.6

 
$
341

 
57,282

 
$
24.44

 
$
1,020

 

 
$

 
$

Awarded
68,361

 
30.19

 

 

 
31,552

 
43.95

 

 
57,282

 
24.44

 

Exercised

 

 

 

 
(25,371
)
 
24.44

 
77

 

 

 

Forfeited

 

 

 

 
(12,992
)
 
43.95

 

 

 

 

Outstanding end of year, December 31,
118,832

 
30.80

 
8.4

 
486

 
50,471

 
31.61

 
341

 
57,282

 
24.44

 
1,020

Exercisable at December 31,
27,458

 
28.84

 
7.5

 
187

 
10,636

 
24.44

 
114

 

 

 

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
The following table presents the changes in non-vested time-based awards during 2012:
 
Shares
 
Weighted-Average
Grant-Date
Fair Value
 
 
 
 
Non-vested at December 31, 2011
527,801

 
$
29.29

Granted
341,338

 
26.59

Vested
(186,205
)
 
29.42

Forfeited
(36,444
)
 
28.20

Non-vested at December 31, 2012
646,490

 
27.93

 
 
 
 

 
As of/Year Ended December 31,
 
2012
 
2011
 
2010
 
(in thousands, except per share data)
 
 
 
 
 
 
Total intrinsic value of time-based awards vested
$
5,950

 
$
9,030

 
$
3,219

Total intrinsic value of time-based awards non-vested
21,470

 
18,531

 
22,211

Market price per common share as of December 31,
33.21

 
35.11

 
42.25

Weighted-average grant date fair value per share
26.59

 
33.71

 
25.04

Restricted Stock Awards, Market-Based, Valuation assumptions [Table Text Block]
In January 2012, the Compensation Committee awarded a total of 30,541 market-based restricted shares to our executive officers. In addition to continuous employment, the vesting of these shares is contingent on the Company's total shareholder return ("TSR"), which is essentially the Company’s stock price change including any dividends, as compared to the TSR of a set group of 14 peer companies. The shares are measured over a three-year period ending on December 31, 2014 and can result in a payout between 0% and 200% of the total shares awarded. The weighted-average grant date fair value per market-based share for these awards granted was computed using the Monte Carlo pricing model using the following assumptions:
 
 
Year Ended December 31,
 
 
2012
 
2011
 
 
 
 
 
Expected term of award
 
3 years

 
3 years

Risk-free interest rate
 
0.3
%
 
1.1
%
Expected volatility
 
65.3
%
 
74.2
%
Weighted-average grant date fair value per share
 
$
36.54

 
$
58.53

Schedule of Nonvested Performance-based Units Activity [Table Text Block]
The following table presents the change in non-vested market-based awards during 2012:
 
 
Shares
 
Weighted-Average
Grant-Date
Fair Value per Share
 
 
 
 
 
Non-vested at December 31, 2011
 
43,081

 
$
42.05

Granted
 
30,541

 
36.54

Forfeited
 
(32,926
)
 
45.15

Non-vested at December 31, 2012
 
40,696

 
39.22

 
 
 
 
 

 
As of/Year Ended December 31,
 
2012
 
2011
 
2010
 
(in thousands, except per share data)
 
 
 
 
 
 
Total intrinsic value of market-based awards vested
$

 
$
366

 
$

Total intrinsic value of market-based awards non-vested
1,352

 
1,513

 
3,361

Market price per common share as of December 31,
33.21

 
35.11

 
42.25

Weighted-average grant date fair value per share
36.54

 
58.53